- Home
- KROS vs HIFS Comparison
KROS vs HIFS Comparison
Compare KROS & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- HIFS
- Stock Information
- Founded
- KROS 2015
- HIFS 1834
- Country
- KROS United States
- HIFS United States
- Employees
- KROS N/A
- HIFS N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- HIFS Major Banks
- Sector
- KROS Health Care
- HIFS Finance
- Exchange
- KROS Nasdaq
- HIFS Nasdaq
- Market Cap
- KROS 565.0M
- HIFS 617.7M
- IPO Year
- KROS 2020
- HIFS N/A
- Fundamental
- Price
- KROS $15.71
- HIFS $297.04
- Analyst Decision
- KROS Buy
- HIFS
- Analyst Count
- KROS 14
- HIFS 0
- Target Price
- KROS $20.56
- HIFS N/A
- AVG Volume (30 Days)
- KROS 370.6K
- HIFS 90.1K
- Earning Date
- KROS 11-05-2025
- HIFS 10-10-2025
- Dividend Yield
- KROS N/A
- HIFS 0.85%
- EPS Growth
- KROS N/A
- HIFS 63.41
- EPS
- KROS 0.47
- HIFS 15.35
- Revenue
- KROS $232,844,000.00
- HIFS $75,066,000.00
- Revenue This Year
- KROS $5,998.31
- HIFS N/A
- Revenue Next Year
- KROS N/A
- HIFS N/A
- P/E Ratio
- KROS $33.68
- HIFS $19.12
- Revenue Growth
- KROS 85820.30
- HIFS 37.00
- 52 Week Low
- KROS $9.12
- HIFS $209.71
- 52 Week High
- KROS $72.37
- HIFS $303.51
- Technical
- Relative Strength Index (RSI)
- KROS 53.11
- HIFS 63.00
- Support Level
- KROS $15.00
- HIFS $252.99
- Resistance Level
- KROS $16.57
- HIFS $276.11
- Average True Range (ATR)
- KROS 0.53
- HIFS 9.88
- MACD
- KROS -0.06
- HIFS 1.35
- Stochastic Oscillator
- KROS 47.77
- HIFS 84.26
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.